tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Purcell, 22 are a BUY (34.38%), 6 are a SELL (9.38%), 36 are a HOLD (56.25%).
Analyst Mark Purcell, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 46.47% that have a potential upside of 17.63% achieved within 247 days. Previously, Mark Purcell worked at BARCLAYS, COLLIERS.
Mark Purcell’s has documented 107 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on NVS, Novartis AG ADR at 26-Mar-2026.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for RH (RH) at 4/28/2020. The price target of $382.61 was fulfilled within 135 days with a profit of $233.67 (156.89%) receiving and performance score of 11.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$240
$53.57 (28.73%)
$105
7 months 10 days ago
(30-Mar-2026)
12/15 (80%)
$47.4 (24.61%)
572
Buy Since 27-Jan-2020
$220
$33.57 (18.01%)
$174
7 months 13 days ago
(27-Mar-2026)
5/16 (31.25%)
$32.82 (17.53%)
570
Buy Since 11-Apr-2023
$109
$-77.43 (-41.53%)
$168
8 months 7 days ago
(02-Mar-2026)
1/3 (33.33%)
$-93.39 (-46.14%)
128
Buy Since 26-Jan-2018
$108.5
$-77.93 (-41.80%)
11 months 15 days ago
(25-Nov-2025)
6/7 (85.71%)
$-74.82 (-40.81%)
856
Hold Since 27-Oct-2025
1 years 13 days ago
(27-Oct-2025)
2/3 (66.67%)
$-6.12 (-4.81%)
958
What Year was the first public recommendation made by Mark Purcell?
